Oral dehydroepiandrosterone for adrenal androgen replacement: Pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 6, 1998, Pages 1928-1934

  Arlt, Wiebke ^a   Justl, Hans Georg ^a   Callies, Frank ^a   Reincke, Martin ^a   Hübler, Doris ^b   Oettel, Michael ^b   Ernst, Michael ^b   Schulte, Heinrich Maria ^c   Allolio, Bruno ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b BAYER PHARMA AG   (Germany)

^c Institut fur Hormon und Fortpflanzungsforschung IHF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANEDIOL; ANDROSTANOLONE; ANDROSTENEDIONE; DEXAMETHASONE; ESTRADIOL; ESTROGEN; ESTRONE; HYDROCORTISONE; PLACEBO; PRASTERONE; PRASTERONE SULFATE; TESTOSTERONE;

ADRENAL INSUFFICIENCY; ADULT; ANDROGEN THERAPY; AREA UNDER THE CURVE; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEXAMETHASONE SUPPRESSION TEST; DRUG BLOOD LEVEL; DRUG POTENCY; DRUG TRANSFORMATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031732821     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.6.4850     Document Type: Article

References (42)

1. Rotter JI, Wong FL, Lifrak ET, Parker LN. 1985 A genetic component to the variation of dehydroepiandrosterone sulfate. Metabolism. 34:731-736.
2. Orentreich N, Brind JL, Rizer RL, Vogelman JH. 1984 Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 59:551-555.
3. Gray A, Feldman HA, McKinlay JB, Longcope C. 1991 Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 73:1016-1025.
4. Orentreich N, Brind JL, Vogelman JH, Andres R, Baldwin H. 1992 Long-term longitudinal measurements of plasma DHEA sulfate in normal men. J Clin Endocrinol Metab. 75:1002-1004.
5. Yen SSC, Morales AJ, Khorram O. 1995 Replacement of DHEA in aging men and women. Potential remedial effects. Ann NY Acad Sci. 774:128-142.
6. Baulieu EE. 1996 Dehydroepiandrosterone (DHEA): a fountain of youth? (editorial) J Clin Endocrinol Metab. 81:3147-3151.
7. Berr C, Lafont S, Debuire B, Dartignes JF, Baulieu EE. 1996 Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, mental status, and short-term mortality: a French community-based study. Proc Natl Acad Sci USA. 93:13410-13415.
8. Ravaglia G, Forti P, Maioli F, et al. 1996 The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results from an Italian study on healthy free-living over-ninety-year-olds. J Clin Endocrinol Metab. 81:1173-1178.
9. Cawood EHH, Bancroft J. 1996 Steroid hormones, the menopause, sexuality and well-being of women. Psychol Med. 26:925-936.
10. Morales AJ, Nolan JJ, Nelson JC, Yen SSC. 1994 Effects of replacement dose of dehydroepiandrosterone in men and women of advanced age. J Clin Endocrinol Metab. 78:1360-1367.
11. Baulieu EE, Robel P. 1996 Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive neurosteroids. J Endocrinol. 150:S221-S239.
12. Friess E, Trachsel L, Guldner J, Schier T, Steiger A, Holsboer F. 1995 DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range. Am J Physiol. 268:E107-E113.
13. Casson PR, Andersen RN, Herrod HG, et al. 1993 Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. Am J Obstet Gynecol. 169:1536-1539.
14. Van Vollenhoven RF, Engleman EG, McGuire JL. 1994 An open study of dehydroepiandrosterone in systemic lupus erythematodes. Arthritis Rheum. 37:1305-1310.
15. Regelson W, Loria R, Kalimi M. 1994 Dehydroepiandrosterone (DHEA)-the "mother steroid". 1. Immunologic action. Ann NY Acad Sci. 719:553-563.
16. Labrie F, Simard J, Luu-The V, Pelletier G, Belghimi K, Belanger A. 1994 Structure, regulation, and role of 3β-hydroxysteroid dehydrogenase, 17β-hydroxysteroid dehydrogenase and aromatase enzymes in the formation of sex steroids in classical and peripheral intracrine tissues. Baillieres Clin Endocrinol Metab. 8:451-474.
17. Oelkers W. 1996 Current concepts: adrenal insufficiency. N Engl J Med. 335:1206-1212.
18. Riedel M, Wiese A, Schürmeyer TH, Brabant G. 1993 Quality of life in patients with Addison's disease: effects of different cortisol replacement modes. Exp Clin Endocrinol. 101:106-111.
19. Young J, Couzinet B, Nahoul K, et al. 1997 Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans. J Clin Endocrinol Metab. 82:2578-2585.
20. Casson PR, Faquin LC, Stentz FB, et al. 1995 Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women. Fertil Steril. 63:1027-1031.
21. Buster JE, Casson PR, Straughn AB, et al. 1942 Postmenopausal steroid replacement with micronized dehydroepiandrosterone: preliminary oral bioavailability and dose proportionality studies. Am J Obstet Gynecol. 166:1163-1170.
22. Nestler JE, Barlascini CO, Clore JN, Blackard WG. 1988 Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab. 66:57-61.
23. Welle S, Jozefowicu R, Statt M. 1990 Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans. J Clin Endocrinol Metab. 71:1259-1264.
24. Mortola JF, Yen SSC. 1990 The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab. 71:696-704.
25. Dyner TS, Lang W, Geaga J, et al. 1993 An open-label dose-escalation trial of oral dehydroepiandrosterone tolerance and pharmacokinetics in patients with HIV disease. J Acquir Immune Defic Syndr. 6:459-465.
26. Casson PR, Straughn AB, Umstot ES, Abraham GE, Carson SA, Buster JE. 1996 Delivery of dehydroepiandrosterone to premenopausal women: effects of micronization and nonoral administration. Am J Obstet Gynecol. 174:649-653.
27. Labrie F, Belanger A, Cusan L, Candas B. 1997 Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J Clin Endocrinol Metab. 82:2403-2409.
28. Falany JL, Lawing L, Falany CN. 1993 Identification and characterization of cytosolic sulfotransferase activities in MCF-7 human breast carcinoma cells. J Steroid Biochem Mol Biol. 46:481-487.
29. Barker EV, Hume R, Hallas A, Coughtrie MWH. 1994 Dehydroepiandrosterone sulfotransferase in the developing human fetus: quantitative biochemical and immunological characterization of the hepatic, renal, and adrenal enzymes. Endocrinology. 134:982-989.
30. Haning RV, Flood CA, Hackett RJ, Loughlin JS, McClure N, Longcope C. 1991 Metabolic clearance rate (MCR) of dehydroepiandrosterone sulfate, its metabolism to testosterone and its intrafollicular metabolism to dehydroepiandrosterone, androstenedione, testosterone, and dihydrotestosterone in vivo. J Clin Endocrinol Metab. 72:1088-1095.
31. Haning RV, Hackett RJ, Boothroid RI, Canick JA. 1990 Steroid sulphatase activity in the human ovarian corpus luteum, stroma, and follicle: comparison to activity in other tissues and the placenta. J Steroid Biochem. 36:175-179.
32. Martel C, Melner MH, Gagne D, Simard J, Labrie F. 1994 Widespread tissue distribution of steroid sulfatase, 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD). 17 beta-HSD, 5-alpha reducatase and aromatase activities in the rhesus monkey. Mol Cell Endocrinol. 104:103-111.
33. Mortaud S, Donsezdarcel E, Roubertoux PL, Degrelle H. 1996 Murine steroid sulfatase gene expression in the brain during postnatal development and adulthood. Neurosci Lett. 215:145-148.
34. Fujikawa H, Okura F, Kuwano Y, et al. 1447 Steroid sulfatase activity in osteoblast cells. Biochem Biophys Res Commun. 231:42-47.
35. Meikle AW, Dorchuck RW, Araneo BA, et al. 1942 The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T-cells. J Steroid Biochem Mol Biol. 42:293-304.
36. Labrie F. 1991 At the cutting edge: intracrinology. Mol Cell Endocrinol. 78:C113-C118.
37. Giagulli VA, Verdonck L, Giorging R, Vermeulen A. 1989 Precursors of plasma androstanediol- and androsterone-glucuronides in normal women. J Steroid Biochem. 33:935-940.
38. Moghissi E, Ablan F, Horton R. 1984 Origin of plasma androstanediol glucuronide in men. J Clin Endocrinol Metab. 59:417-421.
39. Abraham GE. 1974 Ovarian and adrenal contributions to peripheral androgens during the menstrual cycle. J Clin Endocrinol Metab. 39:340-346.
40. Maroulis GB, Abraham GE. 1976 Ovarian and adrenal contributions to peripheral steroid levels in postmenopausal women. Obstet Gynecol. 48:150-154.
41. Haning RV, Austin CW, Carlson ICH, Kuzma DI, Zweibel WJ. 1985 Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis. Obstet Gynecol. 65:199-205.
42. Haning RV, Carlson ICH, Flood CA, Hackett TH, Longcope C. 1991 Metabolism of dehydroepiandrosterone sulfate (DS) in normal women and women with high DS concentrations. J Clin Endocrinol Metab. 73:1210-1215.